Hyundai Bioscience Co. Ltd (048410) — Cash Flow Reinvestment Rate
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Reinvestment Rate of 1.11x as of December 2024, reinvesting ₩2.52 Billion (capex ₩2.17 Billion plus investments ₩-345.74 Million) from operating cash flow of ₩2.26 Billion. Check Hyundai Bioscience Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hyundai Bioscience Co. Ltd across 8 annual periods. Explore Hyundai Bioscience Co. Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Hyundai Bioscience Co. Ltd. For live market cap and broader valuation context, see Hyundai Bioscience Co. Ltd (048410) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 9.71x | ₩21.91 Billion | ₩2.26 Billion | ₩2.17 Billion | ▲ +178.5% |
| 2020 | 3.49x | ₩26.15 Billion | ₩7.50 Billion | ₩25.20 Billion | ▲ +433.9% |
| 2019 | 0.65x | ₩5.99 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -67.3% |
| 2018 | 2.00x | ₩9.99 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -95.2% |
| 2015 | 41.75x | ₩3.65 Billion | ₩87.36 Million | ₩647.57 Million | ▲ +3034.7% |
| 2014 | 1.33x | ₩1.63 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +1874.4% |
| 2011 | 0.07x | ₩267.78 Million | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩3.92 Billion | ₩10.37 Billion | ₩3.92 Billion | — |